Mitigating Immunogenicity Risks Factors In AAV Gene Therapy Clinical Trials

Access key takeaways from a roundtable on the evolving landscape for rAAV-based gene therapies. Experts discussed approaches to clinical development, regulatory barriers, and the future outlook for AAV developers and lab services organizations.